Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906955 · ClinicalTrials.gov registry record · NA
A Video Chat Intervention for Enhancing Self-efficacy for Lifestyle Physical Activity
A NA study, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03906955: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.
NCT03906955 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 72 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03906955, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of three, brief (10-minute) theory-guided video chats for increasing self-efficacy for lifestyle physical activity versus a time-matched video chat comparison group designed to increase self-efficacy for work-life balance. Participants will include individuals who are low-active, full-time (\>35 hours/week) working adults.
Primary Outcome
The SELPA is a 6-item questionnaire that assesses beliefs in one's ability to engage in physical activity of one's own choosing to meet the physical activity guidelines. The SELPA is a modified version of the Lifestyle Efficacy Scale (McAuley, Hall, Motl, Wojcicki, White, Hu, \& Doerksen, 2009). In this study, participants are asked to assess their confidence in their ability to accumulate five or more times per week at a moderate intensity, for at least 30 minutes for six weeks. Each question i
Interventions
- BEHAVIORAL Efficacy for Lifestyle PA
- BEHAVIORAL Efficacy for Work-life Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
What the finished NCT03906955 record still lists
NCT03906955 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Efficacy for Lifestyle PA is the first listed.
NCT03906955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03906955 about?
NCT03906955 is a clinical study titled "A Video Chat Intervention for Enhancing Self-efficacy for Lifestyle Physical Activity". The purpose of this study is to evaluate the efficacy of three, brief (10-minute) theory-guided video chats for increasing self-efficacy for lifestyle physical activity versus a time-matched video chat comparison group designed to increase self-efficacy for work-life balance. Participants will inclu...
What is the current status of trial NCT03906955?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2019-04-09. Estimated completion is 2019-09-15.
What interventions are being tested in trial NCT03906955?
The interventions under investigation include: Efficacy for Lifestyle PA (BEHAVIORAL), Efficacy for Work-life Balance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03906955?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03906955's enrollment target sits among peer trials
72 1089th of 2000 higher than 899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI